semaglutide

noun

sem·a·glu·tide ˌsem-ə-ˈglü-ˌtīd

: a drug C₁₈₇H₂₉₁N₄₅O₅₉ that selectively binds to and activates cell receptors for glucagon-like peptide 1 acting to stimulate insulin secretion and decrease glucagon secretion and that is administered orally or by injection for the management of type 2 diabetes or for the promotion of weight loss in obese patients or in overweight patients with a comorbidity

Note: Semaglutide is marketed under the trademarks Ozempic, Rybelsus, and Wegovy.